Surgical treatment variation in a prospective, randomized trial of chemoradiotherapy in gastric cancer: The effect of undertreatment

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Annals of Surgical Oncology

• Publication date

  2002-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/BF02573066PMID 11923135
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Intersphincteric Resection in Patients with Very Low Rectal Cancer: A Review of the Japanese Experience

  2006cited by this paper
• Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroœsophageal junction

  2002cited by this paper
• Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction.

  2001cited by this paper
• Fundamentals of contemporary surgical oncology: biologic principles and the threshold concept govern treatment and outcomes.

  2001cited by this paper
• Postoperative adjuvant chemoradiation therapy for patients with resected gastric cancer: intergroup 116.

  2001cited by this paper
• Cancer Statistics, 2001

  2001cited by this paper
• Postoperative adjuvant chemoradiation therapy for patients with resected gastric cancer: intergroup 116.

  2001cited by this paper
• The National Cancer Data Base report on poor survival of U.S. gastric carcinoma patients treated with gastrectomy

  2000cited by this paper
• Extended lymph-node dissection for gastric cancer.

  1999cited by this paper
• Lymph-node dissection for gastric cancer.

  1999cited by this paper
• Global cancer statistics

  1999cited by this paper
• Patient survival after D 1 and D 2 resections for gastric cancer: long-term results of the MRC randomized surgical trial

  1999cited by this paper
• Subtotal versus total gastrectomy for gastric cancer: five-year survival rates in a multicenter randomized Italian trial. Italian Gastrointestinal Tumor Study Group.

  1999cited by this paper
• Inadequate documentation and resection for gastric cancer in the United States: a preliminary report.

  1998cited by this paper
• Risk factors for surgical treatment in the Dutch gastric cancer trial

  1997cited by this paper
• Gastric carcinoma: does lymph node dissection alter survival?

  1996cited by this paper
• A prospective randomized trial comparing R1 subtotal gastrectomy with R3 total gastrectomy for antral cancer.

  1996cited by this paper
• Postoperative morbidity and mortality after D1 and D2 resections for gastric cancer: preliminary results of the MRC randomised controlled surgical trial

  1996cited by this paper
• Postoperative morbidity and mortality after D1 and D2 resections for gastric cancer: preliminary results of the MRC randomised controlled surgical trial. The Surgical Cooperative Group.

  1996cited by this paper
• Gastric cancer nodal metastases: biologic significance and therapeutic considerations.

  1996cited by this paper
• Randomised comparison of morbidity after D1 and D2 dissection for gastric cancer in 996 Dutch patients.

  1995cited by this paper
• Pancreas-preserving total gastrectomy for proximal gastric cancer

  1995cited by this paper
• Japanese classification of gastric carcinoma

  1995cited by this paper
• A Prospective Randomized Trial Comparing R1 Subtotal Gastrectomy with R3 Total Gastrectomy for Antral Cancer

  1994cited by this paper
• Should general surgeons treat gastric carcinoma? An audit of practice and results, 1980–1985

  1994cited by this paper
• R2 Dissection in the Treatment of Gastric Malignancy

  1993cited by this paper
• Cancer of the stomach. A patient care study by the American College of Surgeons.

  1993cited by this paper
• Controlled Trials and the R1/R2 Controversy in the Management of Gastric Carcinoma

  1993cited by this paper
• Preoperative assessment of lymph node metastases in patients with gastric cancer: evaluation of the Maruyama computer program

  1992cited by this paper
• Manual for Staging of Cancer

  1992cited by this paper
• Radical surgery for gastric cancer. A review of the Japanese experience

  1989cited by this paper
• Gastric cancer: Different diseases

  1989cited by this paper
• Radical surgery for gastric cancer. A review of the Japanese experience

  1989cited by this paper
• Computer analysis in making preoperative decisions: A rational approach to lymph node dissection in gastric cancer patients

  1989cited by this paper
• Randomized comparison of R1 and R2 gastrectomy for gastric carcinoma

  1988cited by this paper
• The Will Rogers phenomenon. Stage migration and new diagnostic techniques as a source of misleading statistics for survival in cancer.

  1985cited by this paper
• A comparison of combination chemotherapy and combined modality therapy for locally advanced gastric carcinoma

  1982cited by this paper
• Letter: Oral hypoglycaemics in diabetes mellitus.

  1975cited by this paper
• Combined 5-fluorouracil and supervoltage radiation therapy of locally unresectable gastrointestinal cancer.

  1969influential reference
• Radical Surgery for Gastric Cancer

  1945cited by this paper
• Regression Models and Life-Tables

  year unknowncited by this paper

• Historical evolution and current research status of lymph node staging in gastric cancer: a review

  2025cites this paper
• Feasibility of Regional Lymphadenectomy for Stomach-Preserving Surgery in Early Gastric Cancer Omitting Sentinel Node Navigation: A Post Hoc Analysis of the SENORITA Trial

  2024cites this paper
• A combined approach for individualized lymphadenectomy in gastric cancer patients

  2023cites this paper
• Impact of Age on the Treatment and Survival in Esophagogastric Cancer

  2023cites this paper
• Optimal extent of lymph node dissection in gastric cancer

  2022cites this paper
• Comparison of 4 lymph node staging systems for the prognostic prediction of esophagogastric junction adenocarcinoma with ≤15 retrieved lymph nodes.

  2021cites this paper
• Chemoradiotherapy or chemotherapy as adjuvant treatment for resected gastric cancer: should we use selection criteria?

  2021cites this paper
• Surgical Treatment for Gastric Cancer.

  2021cites this paper
• Surgical Management of Gastric Cancer: A Systematic Review

  2021cites this paper
• Challenges to quality assurance of surgical interventions in clinical oncology trials: A systematic review.

  2020cites this paper
• Challenges surrounding postoperative adjuvant chemotherapy for T2N0 gastric cancer.

  2020cites this paper
• Efficacy and adverse effects of olanzapine in the treatment of moderate to severe refractory neuropathic pain

  2020cites this paper
• Prognostic value of a new staging system based on the retrieved number and metastatic rate of LNs in gastric cancer with ≤15 retrieved LNs.

  2020cites this paper
• Impact of surgical resection rate on survival in gastric cancer: nationwide study

  2020cites this paper
• Blast from the past: Perioperative use of the Maruyama computer program for prediction of lymph node involvement in the surgical treatment of gastric cancer following neoadjuvant chemotherapy.

  2019cites this paper
• Surgical Compliance and Outcomes in Gastric Cancer: a population-based cohort study

  2019cites this paper
• In Patients with Localized and Resectable Gastric Cancer, What is the Optimal Extent of Lymph Node Dissection—D1 Versus D2 Versus D3?

  2019cites this paper
• Current status of adjuvant chemotherapy for gastric cancer

  2019cites this paper
• Prognostic and Predictive Factors for the Curative Treatment of Esophageal and Gastric Cancer in Randomized Controlled Trials: A Systematic Review and Meta-Analysis

  2019cites this paper
• Differences in gastric cancer surgery outcome between East and West : differences in surgery or different diseases ?

  2018cites this paper
• Efficacy of Adjuvant S-1 Versus XELOX Chemotherapy for Patients with Gastric Cancer After D2 Lymph Node Dissection: A Retrospective, Multi-Center Observational Study

  2018cites this paper
• Impact of upfront randomization for postoperative treatment on quality of surgery in the CRITICS gastric cancer trial

  2018cites this paper
• Is the 8th Edition of the AJCC TNM Staging System Sufficiently Reasonable for All Patients with Noncardia Gastric Cancer? A 12,549-Patient International Database Study

  2018cites this paper
• Necessity of adjuvant concurrent chemo-radiotherapy in D2-resected LN-positive gastric cancer.

  2018cites this paper
• Efficacy of Adjuvant S-1 Versus XELOX Chemotherapy for Patients with Gastric Cancer After D 2 Lymph Node Dissection : A Retrospective , Multi-Center Observational Study

  2018cites this paper
• Underutilization of Treatment for Regional Gastric Cancer Among the Elderly in the USA

  2018cites this paper
• Association between hospital volume and quality of gastric cancer surgery in the CRITICS trial

  2018cites this paper
• CURRENT STATUS OF THE MULTIDISCIPLINARY TREATMENT OF GASTRIC ADENOCARCINOMA

  2018cites this paper
• Influence of Total Lymph Node Count on Staging and Survival After Gastrectomy for Gastric Cancer: An Analysis From a Two-Institution Database in China

  2017cites this paper
• Lymphadenektomie bei Magenkarzinom und AEG

  2017cites this paper
• Applicability of the Proposed Japanese Model for the Classification of Gastric Cancer Location: The “PROTRADIST” Retrospective Study

  2017cites this paper
• Comparison of changes in renal function with dosimetric parameters in gastric cancer patients treated with adjuvant chemoradiotherapy

  2017cites this paper
• Extent of lymphadenectomy has no impact on postoperative complications after gastric cancer surgery in Sweden

  2017cites this paper
• Perioperative chemotherapy for resectable gastric cancer – what is the evidence?

  2017cites this paper
• Surgicopathological Quality Control and Protocol Adherence to Lymphadenectomy in the CRITICS Gastric Cancer Trial

  2017cites this paper
• Surgical management of advanced gastric cancer: An evolving issue.

  2016cites this paper
• Recent insights in the therapeutic management of patients with gastric cancer.

  2016cites this paper
• Alternative staging of regional lymph nodes in gastric cancer

  2016cites this paper
• Clinical significance of lymphadenectomy in patients with gastric cancer.

  2016cites this paper
• An update on gastric cancer.

  2016cites this paper
• Lymphadenectomy—D1, D2, and D3

  2015cites this paper
• Optimal management of resectable gastric adenocarcinoma

  2015cites this paper
• Quality control of lymph node dissection in the Dutch Gastric Cancer Trial

  2015cites this paper
• Surgical management of gastric cancer: the East vs. West perspective.

  2015cites this paper
• Morbidity and Mortality Associated with Gastrectomy for Gastric Cancer

  2014cites this paper
• Distal Gastrectomy with D2 Nodal Dissection

  2014cites this paper
• Subtotal gastrectomy for gastric cancer.

  2014cites this paper
• Retrospective analysis of adjuvant chemotherapy for curatively resected gastric cancer.

  2014cites this paper
• Mide Kanserli Hastalarda Postoperatif Kemoradyoterapi Sonuçlari: Bülent Ecevit Üniversitesi Deneyimi

  2014cites this paper
• What make differences in the outcome of adjuvant treatments for resected gastric cancer?

  2014cites this paper
• Provincial Gastric and GastroEsophageal Junction Cancer Treatment Guidelines

  2014cites this paper
• Problems faced by evidence-based medicine in evaluating lymphadenectomy for gastric cancer.

  2014cites this paper
• (Neo)-Adjuvant Chemo(-Radio) Therapy for Adenocarcinomas of the Gastroesophageal Junction and the Stomach in the West

  2013cites this paper
• A new metastatic lymph node ratio system reduces stage migration in patients undergoing D 1 lymphadenectomy for gastric adenocarcinoma : analysis of 257 consecutive cases at a single Western institution

  2013cites this paper
• Treatment Trends and Predictors of Adjuvant and Neoadjuvant Therapy for Gastric Adenocarcinoma in the United States

  2013cites this paper
• Lymph Node Dissection in Resectable Advanced Gastric Cancer

  2013cites this paper
• AdjuvantTreatmentforGastricCancer:Chemotherapy VersusRadiation

  2013cites this paper
• D2 Lymphadenectomy with Surgical Ex Vivo Dissection into Node Stations for Gastric Adenocarcinoma Can Be Performed Safely in Western Patients and Ensures Optimal Staging

  2013cites this paper
• Adjuvant treatment for gastric cancer: chemotherapy versus radiation.

  2013cites this paper
• New Metastatic Lymph Node Ratio System Reduces Stage Migration in Patients Undergoing D 1 Lymphadenectomy for Gastric

  2013cites this paper
• Effect of adjuvant chemoradiotherapy on overall survival of gastric cancer patients submitted to D2 lymphadenectomy

  2012cites this paper
• Survival Benefit of Adjuvant Radiation Therapy for Gastric Cancer following Gastrectomy and Extended Lymphadenectomy

  2012cites this paper
• Adjuvant chemoradiotherapy after d2-lymphadenectomy for gastric cancer: the role of n-ratio in patient selection. results of a single cancer center

  2012cites this paper
• Adjuvant Radiation Therapy Increases Overall Survival in Node-Positive Gastric Cancer Patients With Aggressive Surgical Resection and Lymph Node Dissection: A SEER Database Analysis

  2012cites this paper
• How many lymph nodes should be assessed in patients with gastric cancer? A systematic review

  2012cites this paper
• Surgery for gastric cancer: what the trials indicate.

  2012cites this paper
• Gastrointestinal cancer: Adjuvant chemotherapy after D2 gastrectomy for gastric cancer

  2012cites this paper
• Is there a Role for Surgery with Adequate Nodal Evaluation Alone in Gastric Adenocarcinoma?

  2012cites this paper
• Can adjuvant chemoradiotherapy replace extended lymph node dissection in gastric cancer?

  2012cites this paper
• Adjuvant chemotherapy: an option for Asian patients only?

  2012cites this paper
• Multimodal Treatment of Gastric Cancer: Surgery, Chemotherapy, Radiotherapy, and Timing

  2012influential citation
• Gastric cancer eastern experience.

  2012cites this paper
• Standard D2 and modified nodal dissection for gastric adenocarcinoma.

  2012cites this paper
• Duodenum and Small Bowel

  2012cites this paper
• Neoadjuvant or adjuvant therapy for resectable gastric cancer: a systematic review and practice guideline for North America

  2012cites this paper
• Updated analysis of SWOG-directed intergroup study 0116: a phase III trial of adjuvant radiochemotherapy versus observation after curative gastric cancer resection.

  2012cites this paper
• Comparison of a Lymph Node Ratio–Based Staging System With the 7th AJCC System for Gastric Cancer: Analysis of 18,043 Patients From the SEER Database

  2012cites this paper
• Extended lymph node dissection for gastric cancer from a European perspective

  2011cites this paper
• Challenges with Demographic Disparities in Gastric Cancer Care and Survival: Spectral Rather than Black and White

  2011cites this paper
• Long-term results of tailored D2 lymph node dissection after R0 surgery for gastric cancer

  2011cites this paper
• Validation of limited lymphadenectomy for lower‐third gastric cancer based on depth of tumour invasion

  2011cites this paper
• Postoperative chemoradiotherapy in gastric cancer: a phase I study of radiotherapy with dose escalation of oxaliplatin, 5-fluorouracil, and leucovorin (FOLFOX regimen)

  2011cites this paper
• Extended lymphadenectomy improvement of overall survival of gastric cancer patients with perigastric node metastasis

  2011cites this paper
• Gastric cancer and adjuvant chemoradiotherapy: when and where, that's the question.

  2011cites this paper
• Neo-adjuvant chemotherapy followed by surgery and chemotherapy or by surgery and chemoradiotherapy for patients with resectable gastric cancer (CRITICS)

  2011cites this paper
• Impact of adjuvant chemoradiotherapy on overall survival of gastric cancer patients with D2 lymphadenectomy.

  2011cites this paper
• Improved survival in patients with lymph node‐positive gastric cancer who received preoperative radiation

  2011cites this paper
• Cancer de l’estomac

  2011cites this paper
• Treatment of high-risk gastric cancer postoperatively using intensity-modulated radiotherapy: a single-institution experience.

  2011cites this paper
• [Surgery after chemotherapy: gastric cancer].

  2011cites this paper
• Does N ratio affect survival in D1 and D2 lymph node dissection for gastric cancer?

  2011cites this paper
• Present and future status of gastric cancer surgery.

  2011cites this paper
• Enhancement the Prediction of Postoperative Survival in Gastric Cancer by Combining the Negative Lymph Node Count with Ratio Between Positive and Examined Lymph Nodes

  2010cites this paper
• Evaluation of the Adequacy of Lymph Node Dissection in Pylorus-Preserving Gastrectomy for Early Gastric Cancer Using the Maruyama Index

  2010cites this paper
• Impact of the extent of surgery and postoperative chemoradiotherapy on recurrence patterns in gastric cancer.

  2010cites this paper
• Postoperative chemoradiotherapy in gastric cancer--a phase I-II study of radiotherapy with dose escalation of weekly cisplatin and daily capecitabine chemotherapy.

  2010cites this paper
• Adjuvant Chemotherapy with Etoposide, Adriamycin and Cisplatin Compared with Surgery Alone in the Treatment of Gastric Cancer: A Phase III Randomized, Multicenter, Clinical Trial

  2010cites this paper
• Reply to F. Sclafani et al

  2010cites this paper
• Surgical treatment of gastric cancer: 15-year follow-up results of the randomised nationwide Dutch D1D2 trial.

  2010cites this paper
• Expression of thymidylate synthase determines the response of gastric cancer patients undergoing gastrectomy to 5-fluorouracil-based adjuvant chemotherapy

  2010cites this paper